Drug and Alcohol Dependence
Volume 67, Issue 1 , Pages 89-94 , 1 June 2002

GHB use among Australians: characteristics, use patterns and associated harm

Received 1 October 2001 ,Accepted 15 February 2002.

References 

  1. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Psychiatric Association, Washington DC.
  2. Australian Bureau of Criminal Intelligence, 2000. Australian Illicit Drug Report 1999–2000. Australian Bureau of Criminal Intelligence, Canberra.
  3. Centers for Disease Control, 1997. Gamma hydroxybutyrate use—New York and Texas, 1995–1996. Morbid Mort Weekly Report 46, pp. 281–283.
  4. Chin M, Kreutzer R, Dyer J. Acute poisoning from gamma-hydroxybutyrate overdose. Ann. Emerg. Med. 1992;31:716–722
  5. Colombo G, Agabio R, Lobina C, Reali R, Fadda F, Gessa G. Symmetrical generalisation between the discriminative stimulus effects of gamma-hydroxybutyric acid and ethanol: occurrence within narrow dose ranges. Physiol. Behav. 1995;57:105–111
  6. Craig K, Gomez H, McManus J, Bania T. Severe gamma-hydroxybutyrate withdrawal: a case report and literature review. J. Emerg. Med. 2000;18:65–70
  7. Dyer J. Gamma-hydroxybutyrate: a health food product producing coma and seizure-like activity. Am. J. Emerg. Med. 1991;9:321–324
  8. Friedman J, Westlake R, Furman M. ‘Grievous bodily harm’: gamma hydroxybutyrate abuse leading to the Wernicke–Korsakoff syndrome. Neurology. 1996;46:469–471
  9. Galloway G, Frederick S, Staggers F, Gonzales M, Stalcup S, Smith D. Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependency. Addiction. 1997;92:89–96
  10. Kam P, Yoong F. Gamma-hydroxybutyric acid: an emerging recreational drug. Anaesthesia. 1998;53:1195–1198
  11. Kaye, S., Darke, S. Determining a diagnostic cut-off on the severity of dependence scale for cocaine dependence. Addiction, in press.
  12. Mamelak M. Gammahydroxybutyrate: an endogenous regulator of energy metabolism. Neurosci. Biobehav. Rev. 1989;13:187–198
  13. Marwick C. Coma-inducing drug GHB may be reclassified. J. Am. Med. Assoc. 1997;277:1505–1506
  14. Nicholson K, Balster R. GHB: a new and novel drug of abuse. Drug Alcohol Depend. 2001;63:1–22
  15. Ross, J., Darke, S., 1997. Benzodiazepine dependence and psychopathology among heroin users in Sydney. NDARC Technical Report No. 50. National Drug and Alcohol Research Centre, UNSW, Sydney.
  16. SPSS Inc., 1999. spss for Windows Version 9.0. SPSS Inc., Chicago.
  17. Swift W, Copeland J, Hall W. Choosing a diagnostic cut-off for cannabis dependence. Addiction. 1998;93:1681–1692
  18. Topp L, Hando J, Dillon P, Solowij N. Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend. 1999;55:105–115
  19. Topp L, Mattick R. Choosing a cut-off on the Severity of Dependence Scale (SDS) for amphetamine users. Addiction. 1997;92:839–845
  20. Whitten L. Conference highlights increasing GHB abuse. NIDA Notes. 2001;16:10–11

PII: S0376-8716(02)00017-0

Drug and Alcohol Dependence
Volume 67, Issue 1 , Pages 89-94 , 1 June 2002

Article Tools